Articles from HealthWarehouse.com, Inc.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the second quarter ended June 30, 2025, totaled $15.7 million, a 182% increase from the quarter ended June 30, 2024, resulting from 495% growth in partner services revenues. The Company reported net income of $228,000 and Adjusted EBITDA of $568,000 for the quarter.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2025, totaled $15.0 million, a 194% increase from the quarter ended March 31, 2024, resulting from 616% growth in partner services revenues. The Company reported net income of $178,000 and Adjusted EBITDA of $521,000 for the quarter.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today its results of operations for the year ended December 31, 2024. The Company reported net sales for the year of $33.6 million, a 66% increase over the year ended December 31, 2023, resulting from 78% growth in direct-to-consumer and partner services prescription revenues, offset in part by a decline in over-the-counter product sales.

HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2024. The Company reported net sales for the third quarter of $9.0 million, an 89% increase over the same period in 2023, resulting from strong growth in prescription sales revenue. The Company reported net income of $74,000 and Adjusted EBITDA, a non-GAAP measure defined below, of $405,000 for the quarter.

HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2024. The Company reported net sales for the second quarter of 2024 of $5.8 million, a 9% increase over the same period in 2023, resulting from strong growth in partner services and B2C prescription revenue. The Company reported a net loss of $344,000 for the quarter and a net loss of $596,000 for the six months ended June 30, 2024.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.1 million, a 3% decrease from the quarter ended March 31, 2023, resulting from a decline in over-the-counter sales. The Company reported a net loss of $252,412 and EBITDA of $89,723 for the quarter.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today its results of operations for the year ended December 31, 2023. The Company reported net sales for the year of $20.3 million, a 12% increase over the year ended December 31, 2022, resulting from 18% growth in direct-to-consumer and partner services prescription revenues, offset in part by a decline in over-the-counter product sales.

HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and nine months ended September 30, 2023. The Company reported net sales for the third quarter of 2023 of $4.8 million, a 2% increase over the same period in 2022, resulting from growth in B2C revenue despite a 46% decline in over-the-counter segment of B2C revenue. Prescription revenues increased by 10% during the quarter.

HealthWarehouse.com, Inc. (OTC:HEWA) announced today its results of operations for the three and six months ended June 30, 2023. The Company reported net sales for the second quarter of 2023 of $5.3 million, a 27% increase over the same period in 2022, resulting from strong growth in partner services and B2C revenue. The Company reported a net loss of $477,000 for the quarter and a net loss of $825,000 for the six months ended June 30, 2023.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the first quarter ended March 31, 2023, totaled $5.3 million, a 22% increase over the quarter ended March 31, 2022, resulting from strong growth in partner services revenue. The Company reported a net loss of $348,120 for the quarter.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its net sales for the year ended December 31, 2022, totaled $18,142,633, a 12% increase over the year ended December 31, 2021, resulting from strong growth in partner services revenue. The Company reported a net loss of $952,029 for the year, but positive cash flow for the sixth consecutive year, as reflected by its internal non-GAAP measure of Adjusted EBITDA as defined below, which was $146,787 in 2022.

HealthWarehouse.com, Inc. (OTC:HEWA) announced today that net sales for the third quarter of 2022 totaled $4,681,302, an 11% increase over the same period in 2021, resulting from strong growth in partner services revenue. The Company reported a loss from operations of $225,614 for the quarter, but positive cash flow, as reflected by its internal non-GAAP measure of Adjusted EBITDA as defined below, which was $47,673 in the third quarter.

HealthWarehouse.com, Inc. (OTC:HEWA) announced today net sales for the first quarter of 2022 totaled $4,314,980, a 13% increase over the same period in 2021, resulting from strong growth in partner services revenue and an increase in direct-to-consumer sales. The Company reported a loss from operations of $213,988 for the quarter while generating positive cash flow of $64,047, as reflected by Adjusted EBITDA (the Company’s non-GAAP internal measure).

HealthWarehouse.com, Inc. (OTCQB: HEWA) announced today net sales for 2021 were $16,143,906, with prescription sales increasing by 2% which was driven by a strong increase in partner services revenue. The growth in prescription revenue was offset by a decrease in over-the-counter business, resulting in an overall 6% decrease in revenues from 2020. The Company reported a loss from operations of $572,502 for the year.

HealthWarehouse.com, Inc. (OTCQB: HEWA) announced net sales for the third quarter of 2021 were $4,212,127, a 5% increase from the same quarter in 2020, with prescription sales increasing 13%. The Company reported a loss from operations of $181,031 for its quarter ended September 30, 2021, but positive cash flow, as reflected by its internal non-GAAP measure of Adjusted EBITDA as defined below, which was $89,797 in the third quarter.

HealthWarehouse.com, Inc. (OTC: HEWA) announced today a loss from operations of $181,811 for its quarter ended June 30, 2021, but positive cash flow, as reflected by its internal measure of Adjusted EBITDA as defined below, which was $87,636 in the second quarter. Net sales for the second quarter of 2021 were $3,954,892, a 13% decrease from the same quarter in 2020.

HealthWarehouse.com, Inc. (OTCQB: HEWA) announced today that it reported a net loss of $131,025 for the first quarter ended March 31, 2021, but positive cash flow, as reflected by its non-GAAP internal measure of Adjusted EBITDA as defined below, which was $124,114 in the first quarter. Net sales for the first quarter of 2021 were $3,818,285, a 16% decrease from the same quarter in 2020.

HealthWarehouse.com, Inc. (OTCQB:HEWA) announced today that its shares of common stock have been approved for listing on the OTCQB Market. The shares of common stock will commence trading today under the ticker symbol "HEWA.”